Literature DB >> 9153220

Characterization of functional domains within Smad4/DPC4.

M P de Caestecker1, P Hemmati, S Larisch-Bloch, R Ajmera, A B Roberts, R J Lechleider.   

Abstract

Smad proteins are a family of highly conserved, intracellular proteins that signal cellular responses downstream of transforming growth factor-beta (TGF-beta) family serine/threonine kinase receptors. One of these molecules, Smad4, originally identified as the candidate tumor suppressor gene dpc-4, reconstitutes TGF-beta- and activin-dependent transcriptional responses in Smad4 null cell lines and interacts in a ligand-dependent manner with other Smad family members in both TGF-beta, activin, and bone morphogenetic protein-2/-4 pathways. Here, we used an assay based on the restoration of ligand-dependent transcriptional responses in a Smad4 null cell line to characterize functional domain structures within Smad4. We showed that restoration of TGF-beta-induced transcriptional responses by Smad4 was inhibited by co-transfection with a kinase dead TGF-beta type II receptor and that constitutive activation was blocked with TGF-beta neutralizing antibodies, confirming the essential role of Smad4 in TGF-beta signaling. Using a series of Smad4 mutation, deletion, and Smad1/Smad4 chimera constructs we identified a 47-amino acid deletion within the middle-linker region of Smad4 that is essential for the mediation of signaling responses. In addition, we showed that the NH2-terminal domain of Smad4 augments ligand-dependent activation associated with the middle-linker region, indicating that there is a distinct ligand-response domain within the N terminus of this molecule.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153220     DOI: 10.1074/jbc.272.21.13690

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction.

Authors:  R H Kim; D Wang; M Tsang; J Martin; C Huff; M P de Caestecker; W T Parks; X Meng; R J Lechleider; T Wang; A B Roberts
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

2.  Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta.

Authors:  Shiyou Chen; Magdalena Kulik; Robert J Lechleider
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

3.  CREBZF, a novel Smad8-binding protein.

Authors:  Jae-Ho Lee; Geun Taek Lee; Seok Joo Kwon; Jeongyun Jeong; Yun-Sok Ha; Wun-Jae Kim; Isaac Yi Kim
Journal:  Mol Cell Biochem       Date:  2012-06-16       Impact factor: 3.396

4.  High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells.

Authors:  T A Sohn; G H Su; B Ryu; C J Yeo; S E Kern
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

5.  Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases.

Authors:  M P de Caestecker; W T Parks; C J Frank; P Castagnino; D P Bottaro; A B Roberts; R J Lechleider
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

6.  Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator.

Authors:  T Shioda; R J Lechleider; S L Dunwoodie; H Li; T Yahata; M P de Caestecker; M H Fenner; A B Roberts; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

7.  Inhibition of BMP2-induced bone formation by the p65 subunit of NF-κB via an interaction with Smad4.

Authors:  Shizu Hirata-Tsuchiya; Hidefumi Fukushima; Takenobu Katagiri; Satoshi Ohte; Masashi Shin; Kenichi Nagano; Kazuhiro Aoki; Takahiko Morotomi; Goro Sugiyama; Chihiro Nakatomi; Shoichiro Kokabu; Takahiro Doi; Hiroshi Takeuchi; Keiichi Ohya; Masamichi Terashita; Masato Hirata; Chiaki Kitamura; Eijiro Jimi
Journal:  Mol Endocrinol       Date:  2014-07-16

8.  Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.

Authors:  J M Yingling; M B Datto; C Wong; J P Frederick; N T Liberati; X F Wang
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

9.  G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation.

Authors:  J L Dai; R K Bansal; S E Kern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.

Authors:  Zhan Hua; Yuan-Chun Zhang; Xiao-Ming Hu; Zhen-Geng Jia
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.